These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 535124)

  • 21. Comparison of CNS-leukaemia in children with acute leukaemia, induced either with rubidomycin or L-asparaginase.
    de Vaan GA; Marcar JR; Schretlen ED
    Padiatr Padol; 1971; 6(3):230-9. PubMed ID: 5293526
    [No Abstract]   [Full Text] [Related]  

  • 22. [Sudden death in leukemic patients treated with doxorubicin].
    Lacasse Y; Bolduc P
    Can J Cardiol; 1992; 8(1):53-6. PubMed ID: 1617512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxic cardiomyopathies.
    Balazs T; Herman EH
    Ann Clin Lab Sci; 1976; 6(6):467-76. PubMed ID: 793502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cardiac toxicity due to daunomycin].
    Kaufman S; Golik A; Yona R; Reif R
    Harefuah; 1980 Dec; 99(11):365-6. PubMed ID: 6946039
    [No Abstract]   [Full Text] [Related]  

  • 25. [Organ toxicity and efficacy of high-dose daunorubicin-based chemotherapy in the treatment of acute leukemia].
    Liu QG; Zhao X; Xu N; Wu LH; Li SZ; Mi YC
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jul; 34(7):587-90. PubMed ID: 23906451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination chemotherapy with cytosine arabinoside and rubidomycin in 30 cases of acute granulocytic leukemia.
    Gluckman E; Basch A; Varet B; Dreyfus B
    Cancer; 1973 Mar; 31(3):487-91. PubMed ID: 4511906
    [No Abstract]   [Full Text] [Related]  

  • 27. Proceedings: Daunorubicin cardiac toxicity in children with acute lymphocytic leukemia.
    Halazun JF; Wagner HR; Gaeta JF; Sinks LF
    Cancer; 1974 Feb; 33(2):545-54. PubMed ID: 4521474
    [No Abstract]   [Full Text] [Related]  

  • 28. [Rubidomycin-daunomycin, a new antibiotic with antineoplastic effect].
    Dano K; Nissen NI
    Nord Med; 1968 Oct; 80(44):1469-74. PubMed ID: 5247179
    [No Abstract]   [Full Text] [Related]  

  • 29. [A successful allogeneic bone marrow transplantation for acute promyelocytic leukemia with anthracycline-induced cardiomyopathy at relapse].
    Azuno Y; Hiroshige Y; Tanaka M; Nishimura Y; Tanaka H; Ueda K; Nishimura M; Okafuji K; Seguchi M; Yoshida T
    Rinsho Ketsueki; 1992 Apr; 33(4):445-50. PubMed ID: 1602607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Attemp at treatment of acute leukemia and Hodgkin's disease by rubidomycin or daunomycin alone or combined].
    Mathe G; Amiel JL; Hayat M; Schwarzenberg L; Schenider M; Cattan A; Schlumberger JR; Ceoara B
    Sem Hop; 1967 Jul; 43(32):2108-14. PubMed ID: 4328374
    [No Abstract]   [Full Text] [Related]  

  • 31. Development of a new intensive therapy for acute lymphoblastic leukemia in children at increased risk of early relapse. The Memorial Sloan-Kettering-New York-II protocol.
    Steinherz PG; Redner A; Steinherz L; Meyers P; Tan C; Heller G
    Cancer; 1993 Nov; 72(10):3120-30. PubMed ID: 8221579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Rubidomycin in acute leukemia in children].
    Armata J; Cyklis R; Garwicz S; Halikowski B; Wyszkowski J
    Pediatr Pol; 1969 Oct; 44(11):1405-12. PubMed ID: 5261217
    [No Abstract]   [Full Text] [Related]  

  • 33. Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia.
    Clavio M; Venturino C; Pierri I; Garrone A; Miglino M; Canepa L; Balleari E; Balocco M; Michelis GL; Ballerini F; Gobbi M
    Ann Hematol; 2004 Nov; 83(11):696-703. PubMed ID: 15322763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes in myocardial function in patients with acute leukemias under the influence of rubomycin].
    Bessmel'tsev SS; Abdulkadyrov KM
    Ter Arkh; 1994; 66(11):80-4. PubMed ID: 7900029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fatty degeneration of myocardial cells as a sign of death due to hypothermia versus degenerative deposition of lipofuscin.
    Preuss J; Dettmeyer R; Lignitz E; Madea B
    Forensic Sci Int; 2006 May; 159(1):1-5. PubMed ID: 16039082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for development of daunorubicin cardiotoxicity.
    Von Hoff DD; Layard M
    Cancer Treat Rep; 1981; 65 Suppl 4():19-23. PubMed ID: 7049377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain natriuretic peptide is a predictor of anthracycline-induced cardiotoxicity.
    Okumura H; Iuchi K; Yoshida T; Nakamura S; Takeshima M; Takamatsu H; Ikeno A; Usuda K; Ishikawa T; Ohtake S; Matsuda T
    Acta Haematol; 2000; 104(4):158-63. PubMed ID: 11279304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Long-term study of anthracycline-induced cardiomyopathy in children and adolescents].
    Koch H; Schmitz L; Brockmeier K; Hartmann R; Bein G; Henze G
    Klin Padiatr; 1991; 203(4):262-7. PubMed ID: 1942932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological features of fatal cardiomyopathy in childhood: an autopsy series.
    Roberts SE; Pryce JW; Weber MA; Malone M; Ashworth MT; Sebire NJ
    J Paediatr Child Health; 2012 Aug; 48(8):675-80. PubMed ID: 22515160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary results in secondary acute non-lymphocytic leukemia (ANLL) treated with Idarubicin.
    Parmentier C; Finaud M; Schlumberger M; Morardet N; Berger R; Bayle C; Carde P; Hurteloup P; Hayat M
    Nouv Rev Fr Hematol (1978); 1985; 27(6):393-5. PubMed ID: 3867854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.